Travere Therapeutics
TVTX
TVTX
59 hedge funds and large institutions have $186M invested in Travere Therapeutics in 2014 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 27 increasing their positions, 7 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
35% less capital invested
Capital invested by funds: $286M → $186M (-$100M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
59
Holding in Top 10
1
Calls
$2.67M
Puts
$625K
Top Buyers
| 1 | +$14.5M | |
| 2 | +$3.56M | |
| 3 | +$2.7M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.11M |
| 5 |
SAM
Senzar Asset Management
New York
|
+$1.86M |
Top Sellers
| 1 | -$5.55M | |
| 2 | -$4.19M | |
| 3 | -$2.77M | |
| 4 |
Jane Street
New York
|
-$2.53M |
| 5 |
CCA
Catalyst Capital Advisors
Huntington,
New York
|
-$1.8M |